Comments
The Rs 150-crore Ozone group, whose flagship brand is Nomarks, under which a range of products are sold for blemish-free skin, intends to achieve a turnover of Rs 1,000 crore by 2015-16. Giving Nomarks a big push is part of the five-year plan.
Not to sell brand
Speaking to Business Line here, Mr S. C. Sehgal, Chairman and Managing Director, Ozone group, said that though he was ambitious for Nomarks, he has, for the time being, reconsidered his willingness to sell the brand as reported in the media a couple of months ago. The Rs 60-crore brand has not “got the attention it qualified for”, he said, adding that he aims for the brand to make at least Rs 20 crore in sales per month before considering a sale of any sort. (when was it launched).
Mr Sehgal said he had “spread myself a little thin without professionalising” the business but that he was making amends now by appointing experienced people. Earlier, too few people were handling too many things, he added. The Ozone group has interests in pharmaceuticals, organic, herbal and ayurvedic farming and products and is partnering the Assam Government to set up a mega food park near Guwahati to enhance infrastructure for food processing and benefit the farmers and food processing industry of North east region.
Distribution is a bugbear that Mr Sehgal readily admits he needs to address. A Rs 26-crore, integrated campaign to market Nomarks will launch late this month. The company’s latest launch is an age-specific range of skin care products, which, Mr Sehgal claims is a first in the industry. Skin care industry size, estimate. He claims fairness is only a ‘lower-order’ benefit in Nomarks; according to him, it no longer defines beauty. The fairness products market in India is estimated at Rs 2,000 crore.
Ozone has launched the Professional range of products for beauty salons and will set up Oscar Skin Institute, an R & D facility, on its farm near the Delhi-Haryana border by January next year. It is investing Rs 30 crore in that facility. It is spending Rs 100 crore on infrastructure for the food park in Assam and hopes to commission it in 2012. It plans to add dental and dermatological specialities to its pharma business, where it works on orthopaedic, gynaecological and cardiac/diabetes drugs.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.